Genmab · 1 day ago
Global Data & Governance Intern
Genmab is an international biotechnology company dedicated to improving patients' lives through innovative antibody therapeutics. The Global Data & Governance Intern will work closely with stakeholders to design and implement data and analytics solutions, gaining hands-on experience and contributing to impactful projects.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Collaborate with stakeholders to understand project requirements and objectives
Design and implement solutions using technologies such as SQL, Python, Spark, R, HTML, AI, and analytics tools
Perform data analysis using SQL, Python or R to derive insights & catalog the data
Support data governance initiatives (e.g., defining data standards, create data/process flow maps, documenting SOPs, and helping initiate and curate entries in the enterprise data catalog)
Contribute to real-impact projects that support the organization’s strategic goals
Participate in personal and professional development sessions with business owners and leaders
Work both independently and collaboratively to achieve project milestones
Present findings, outcomes, and key learnings to stakeholders at the conclusion of the internship
Qualification
Required
Currently pursuing a Bachelor's or Master's degree
Major in Computer Science, Computer Engineering, Data Science, Business Information Management, Information Technology, or a related field
Proficiency in SQL, Python, Spark, R, and HTML
Familiarity with AI and analytics concepts
Strong understanding of data modeling and data analytics
Excellent problem-solving skills
Effective written and verbal communication skills
Preferred
Self-disciplined and proactive, with the ability to work independently as well as collaboratively within a team
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Recent News
2026-01-08
Company data provided by crunchbase